These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26877068)

  • 1. Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
    Shendre A; Brown TM; Liu N; Hill CE; Beasley TM; Nickerson DA; Limdi NA
    Pharmacotherapy; 2016 Mar; 36(3):263-72. PubMed ID: 26877068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.
    Cavallari LH; Perera M; Wadelius M; Deloukas P; Taube G; Patel SR; Aquino-Michaels K; Viana MA; Shapiro NL; Nutescu EA
    Pharmacogenet Genomics; 2012 Feb; 22(2):152-8. PubMed ID: 22158446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of warfarin dosing in patients of African and European ancestry.
    Shendre A; Dillon C; Limdi NA
    Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.
    Shalansky S; Lynd L; Richardson K; Ingaszewski A; Kerr C
    Pharmacotherapy; 2007 Sep; 27(9):1237-47. PubMed ID: 17723077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
    Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid
    Sato Y; Hishinuma E; Yamazaki S; Ueda A; Kumondai M; Saito S; Tadaka S; Kinoshita K; Nakayoshi T; Oda A; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2023 Dec; 51(12):1561-1568. PubMed ID: 37775333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.
    Daneshjou R; Gamazon ER; Burkley B; Cavallari LH; Johnson JA; Klein TE; Limdi N; Hillenmeyer S; Percha B; Karczewski KJ; Langaee T; Patel SR; Bustamante CD; Altman RB; Perera MA
    Blood; 2014 Oct; 124(14):2298-305. PubMed ID: 25079360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial).
    Fahmi AM; El Bardissy A; Saad MO; Elshafei MN; Bader L; Mahfouz A; Kasem M; Abdelsamad O; Elzouki A; Aquilante CL; Mraiche F; Soaly E; El Madhoun I; Asaad N; Arabi A; Alhmoud E; Elewa H
    Clin Transl Sci; 2024 Jun; 17(6):e13797. PubMed ID: 38859626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization.
    Xue L; Ma G; Holford N; Qin Q; Ding Y; Hannam JA; Ding X; Fan H; Ji Z; Yang B; Shen H; Shen Z; Miao L
    Clin Pharmacol Ther; 2024 Jun; 115(6):1316-1325. PubMed ID: 38439157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.
    Roth JA; Bradley K; Thummel KE; Veenstra DL; Boudreau D
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):619-27. PubMed ID: 25858232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide Association Study Identifies Copy Number Variants Associated With Warfarin Dose Response and Risk of Venous Thromboembolism in African Americans.
    Zhang H; Alarcon C; Cavallari LH; Nutescu E; Carvill GL; Perera MA; Hernandez W
    Clin Pharmacol Ther; 2023 Mar; 113(3):624-633. PubMed ID: 36507737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of major hemorrhage for outpatients treated with warfarin.
    McMahan DA; Smith DM; Carey MA; Zhou XH
    J Gen Intern Med; 1998 May; 13(5):311-6. PubMed ID: 9613886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction.
    Schalekamp T; van Geest-Daalderop JH; Kramer MH; van Holten-Verzantvoort AT; de Boer A
    Eur J Clin Pharmacol; 2007 Apr; 63(4):335-43. PubMed ID: 17318526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate.
    Tippin T; Faison S; Schuck V; Dunn J; Naderer O
    Clin Pharmacol Drug Dev; 2024 Mar; 13(3):288-296. PubMed ID: 38171911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalosporins with warfarin increase the risk of bleeding: myth or fact?
    Thabit AK; Almoalim SY; Altalhi R
    Expert Opin Drug Metab Toxicol; 2024 May; 20(5):293-296. PubMed ID: 38712794
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting prolonged dose titration in patients starting warfarin.
    Finkelman BS; French B; Bershaw L; Brensinger CM; Streiff MB; Epstein AE; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1228-1235. PubMed ID: 27456080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Approach towards Minimizing the Risk of Misdosing Warfarin Initiation Doses.
    Sharabiani A; Nutescu EA; Galanter WL; Darabi H
    Comput Math Methods Med; 2018; 2018():5340845. PubMed ID: 29861781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
    Johnson JA; Caudle KE; Gong L; Whirl-Carrillo M; Stein CM; Scott SA; Lee MT; Gage BF; Kimmel SE; Perera MA; Anderson JL; Pirmohamed M; Klein TE; Limdi NA; Cavallari LH; Wadelius M
    Clin Pharmacol Ther; 2017 Sep; 102(3):397-404. PubMed ID: 28198005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the
    Sun X; Yu WY; Ma WL; Huang LH; Yang GP
    Biomed Rep; 2016 Apr; 4(4):498-506. PubMed ID: 27073641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.
    Takeuchi M; Kobayashi T; Biss T; Kamali F; Vear SI; Ho RH; Bajolle F; Loriot MA; Shaw K; Carleton BC; Hamberg AK; Wadelius M; Hirono K; Taguchi M; Wakamiya T; Yanagimachi M; Hirai K; Itoh K; Brandão LR; Ito S
    Pharmacogenomics J; 2020 Apr; 20(2):306-319. PubMed ID: 31673144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.